Main Number 646-604-2760

     Register for $2395. Register 3 people at the same time and get 15% off

        Register Online or contact Glen Van Dusen on 646-604-2830 or at

*Access to the co-located 2nd Peptide Drug Design & Delivery Summit and 4th Controlled & Modified Drug Release Summit is also included in the price.

Event Summary

Drug delivery strategy plays a major role within the future potential success of your product. Whether nurturing a new compound or developing a line of generic products, choosing the most effective delivery strategy can open the door to both opportunities, and hurdles. According to Markets and Markets, the drug delivery technologies market will eclipse $224 billion by 2017.

With an increasing diversity of compounds addressing more drug targets, the available range and sophistication of delivery technologies has expanded with the goal of increasing the successful rate of new chemical entities. Peptides, proteins, and nucleic acids also face similar delivery challenges.

September’s unique 3rd Drug Delivery Strategy: Advanced Mechanisms & Product Design event will showcase innovative delivery strategy examples from the industry’s leading delivery experts and manufacturers. With formulation playing a major role in the successes of a product, the right delivery platform, partnership sourcing and management of collaborations will be explored through a combination of novel case examples, keynote sessions and networking activities. Additionally, hear future regulatory and delivery technology updates, which will keep you ahead of the curve with your products. Topics include:

  • Localized & targeted delivery
  • Pediatric dosage forms & delivery
  • QBD Strategy
  • Novel alliance management strategies
  • Enhancing patient adherence for drug delivery
  • Evaluating innovations in oral drug formulation and delivery technologies
  • Implementing innovative strategies around drug / device combinations
  • Advances in ocular delivery
  • Parenteral routes of administration
  • Topical and Transdermal Delivery
  • Modified release technologies for product lifecycle extensions
This event is tri-located with:
4th Annual Controlled & Modified Drug Release
2nd Peptide Drug Design & Delivery Summit
Attendees will have access to all 3 events throughout the 2 days!

Benefits of Attending

Industry-led Speakers

Senior Participants

Networking Hours

Featured Speakers

Who Should Attend

Pharmaceutical, biotech and academic professionals specializing in:

  • Drug Delivery
  • Pharmaceutics
  • PK-PD
  • Physiochemistry
  • Formulation / Pre-Formulation
  • Medicinal / Analytical / Solid state Chemistry
  • Preclinical / Analytical Development
  • Product Enhancement / Development
  • CMC
  • Regulatory Affairs
  • Drug Discovery
  • Life-Cycle / Portfolio Management
  • Partnering, Licensing & Alliance Management
  • Intellectual Property
  • Toxicology
  • Process R&D

2016’s Participating Companies Include


  • Agios Pharmaceuticals
  • Alcami
  • Amgen
  • Aradigm
  • Ashland
  • BDD
  • Bill & Mellinda Gates Foundation
  • Biogen
  • BioPharma Services
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Catalent
  • Cleave Biosciences
  • Colorcon
  • Dalton Pharma Services
  • Enteris Biopharma
  • Evonik
  • FDA
  • Forsee Pharma
  • Frontage Labs
  • Gilead Sciences
  • GlaxoSmithKline
  • Genentech
  • Johnson & Johnson
  • KVK Tech
  • L’Oreal
  • Lauren Sciences LLC
  • Merck & Co.
  • Microchips Biotech
  • NOF America
  • Novartis
  • Pfizer
  • Piramal Pharma
  • Princeton University
  • Purdue University
  • R.W. Hartnett Company
  • Shire
  • Schrodinger
  • Takeda
  • University of South Carolina
  • University of The Sciences
  • XenoPort
  • And many more…

Past Event Brochure


Download Brochure
Contact Glen Van Dusen on +1-646-604-2830


Our Sponsors

Juniper Pharmaceuticals
Fluid Air
Absorption Systems

Free Content Downloads

Advances in Topical & Transdermal Delivery of Biopharmaceutical Drug Products
Advances in Topical & Transdermal Delivery of Biopharmaceutical Drug Products
Resourcing Innovation for Biologics
Resourcing Innovation for Biologics
Opportunities for Inhaled Antibiotics in CF, Bronchiectasis, NTM and Biodefense Applications
Opportunities for Inhaled Antibiotics in CF, Bronchiectasis, NTM and Biodefense Applications

Pin It on Pinterest

Share This